HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays

• Shih-Wen Lin ,

  * E-mail: lins4@mail.nih.gov

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Arpita Ghosh,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Carolina Porras,

  Affiliation Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

  ⨯
• Sarah C. Markt,

  Affiliation Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Ana Cecilia Rodriguez,

  Affiliation Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

  ⨯
• Mark Schiffman,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Sholom Wacholder,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Troy J. Kemp,

  Affiliation HPV Immunology Laboratory, SAIC-Frederick Inc., NCI-Frederick, Frederick, Maryland, United States of America

  ⨯
• Ligia A. Pinto,

  Affiliation HPV Immunology Laboratory, SAIC-Frederick Inc., NCI-Frederick, Frederick, Maryland, United States of America

  ⨯
• Paula Gonzalez,

  Affiliation Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

  ⨯
• Nicolas Wentzensen,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Mark T. Esser,

  Affiliation MedImmune, Gaithersburg, Maryland, United States of America

  ⨯
• Katie Matys,

  Affiliation PPD Vaccines and Biologics Center of Excellence, Wayne, Pennsylvania, United States of America

  ⨯
• Ariane Meuree,

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• Wim Quint,

  Affiliation DDL Diagnostic Laboratory, Voorburg, The Netherlands

  ⨯
• Leen-Jan van Doorn,

  Affiliation DDL Diagnostic Laboratory, Voorburg, The Netherlands

  ⨯
• Rolando Herrero,

  Affiliation Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Allan Hildesheim,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Mahboobeh Safaeian,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Costa Rican Vaccine Trial Group

  ¶Membership of the Costa Rican Vaccine Trial Group is provided in the Acknowledgments

  ⨯
• [ view all ]
• [ view less ]